ArticleCureus2026
Plasma Exchange for Thrombotic Microangiopathy Associated With Rectal Cancer Presenting With Acute Kidney Injury: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombotic microangiopathy (TMA) is an acute syndrome characterized by microangiopathic hemolytic anemia, thrombocytopenia, and ischemic end-organ damage resulting from platelet-rich microthrombi obstructing the microvasculature. The kidney is particularly vulnerable to TMA-mediated injury due to its numerous microvessels, often leading to acute kidney injury (AKI). AKI induced by TMA can manifest in oncological conditions, although infrequently. Rectal cancer presenting with TMA-related AKI as the initial manifestation is even rarer, posing a diagnostic challenge for nephrologists. We describe a 62-year-old man admitted with AKI followed by severe thrombocytopenia and anemia. During the diagnostic workup to exclude thrombotic thrombocytopenic purpura, the patient achieved complete hematological recovery after hemodialysis and plasma exchange (PEX), which enabled the performance of a renal biopsy. The underlying etiology was TMA on renal biopsy. However, persistent elevation of lactate dehydrogenase and new‑onset of bone pain prompted further evaluation. The magnetic resonance imaging scan and positron emission tomography-computed tomography subsequently confirmed rectal cancer with bone and liver metastases. This case illustrates that AKI secondary to cancer-related TMA may present as the initial clinical manifestation of an underlying malignancy. Renal biopsy plays a crucial role in establishing a definitive diagnosis and guiding subsequent management. Furthermore, PEX was associated with hematological improvement in this patient, but its overall clinical benefit remains to be determined as the patient remained dialysis‑dependent.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.